Skip to Main Content

Author Details

Paul H Duray
National Cancer Institute, National Institutes of Health
1980
167
58
PMIDPaper TitleJournal TitlePublished Year
18162768Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").Am J Surg Pathol2008
18162768Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").Am J Surg Pathol2008
17160014Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.Oncogene2007
17160014Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.Oncogene2007
16640539The effects of gp100 and tyrosinase peptide vaccinations on nevi in melanoma patients.J Cutan Pathol2006
16640539The effects of gp100 and tyrosinase peptide vaccinations on nevi in melanoma patients.J Cutan Pathol2006
17034530Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.Br J Dermatol2006
17127737Morphological characterization of the breast in Proteus syndrome complicated by ductal carcinoma in situ.Ann Clin Lab Sci2006
17034530Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.Br J Dermatol2006
17127737Morphological characterization of the breast in Proteus syndrome complicated by ductal carcinoma in situ.Ann Clin Lab Sci2006
15735850Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.Int J Surg Pathol2005
15735850Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.Int J Surg Pathol2005
15838803Invasion of human tissue ex vivo by Borrelia burgdorferi.J Infect Dis2005
16203770Molecular alterations in primary prostate cancer after androgen ablation therapy.Clin Cancer Res2005
16230383Gene expression profiling of human sarcomas: insights into sarcoma biology.Cancer Res2005
16203770Molecular alterations in primary prostate cancer after androgen ablation therapy.Clin Cancer Res2005
16230383Gene expression profiling of human sarcomas: insights into sarcoma biology.Cancer Res2005
15838803Invasion of human tissue ex vivo by Borrelia burgdorferi.J Infect Dis2005
14755246Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.Oncogene2004
15592675Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.World J Urol2004
15236317Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.Genes Chromosomes Cancer2004
15194572Immunohistochemistry of normal human knee synovium: a quantitative study.Ann Rheum Dis2004
14755246Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.Oncogene2004
15592675Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.World J Urol2004
15194572Immunohistochemistry of normal human knee synovium: a quantitative study.Ann Rheum Dis2004
15236317Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.Genes Chromosomes Cancer2004
12447372High frequency of BRAF mutations in nevi.Nat Genet2003
12447372High frequency of BRAF mutations in nevi.Nat Genet2003
12522379Facial papules, spontaneous pneumothorax, and renal tumors.J Am Acad Dermatol2003
12576923Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.Am J Clin Oncol2003
12931550Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?Am J Clin Pathol2003
12687609Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications.Proteomics2003
12852695A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.Acta Oncol2003
12772087Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.Am J Hum Genet2003
12826605Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.Proc Natl Acad Sci U S A2003
12946221Lyme-associated parkinsonism: a neuropathologic case study and review of the literature.Arch Pathol Lab Med2003
12766610Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis.Diagn Mol Pathol2003
14744091Metastatic nevoid melanoma in a 4 1/2-year-old child.J Cutan Pathol2003
14569130A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.J Med Genet2003
14744091Metastatic nevoid melanoma in a 4 1/2-year-old child.J Cutan Pathol2003
12931550Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?Am J Clin Pathol2003
12946221Lyme-associated parkinsonism: a neuropathologic case study and review of the literature.Arch Pathol Lab Med2003
14569130A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.J Med Genet2003
12576923Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.Am J Clin Oncol2003
12687609Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications.Proteomics2003
12852695A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.Acta Oncol2003
12772087Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.Am J Hum Genet2003
12766610Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis.Diagn Mol Pathol2003
12826605Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.Proc Natl Acad Sci U S A2003
12522379Facial papules, spontaneous pneumothorax, and renal tumors.J Am Acad Dermatol2003
  • 1 - 50 of 334

Recommended Authors

National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 5
12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 1
Sestre milosrdnice University Hospital Centre
Career Start Year 2005
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 2004
Number of shared co-authors 1
Westmead Hospital
Career Start Year 2004
Number of shared co-authors 0
Uppsala University
Career Start Year 2002
Number of shared co-authors 0
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 4
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Royal Jubilee Hospital, University of British Columbia
Career Start Year 2000
Number of shared co-authors 2
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 1999
Number of shared co-authors 11
Wayne State University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 1
Kansas City VA Medical Center
Career Start Year 1998
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Prince of Wales Hospital
Career Start Year 1995
Number of shared co-authors 4
Washington University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Nancy University Hospital
Career Start Year 1993
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
Addenbrooke's Hospital
Career Start Year 1991
Number of shared co-authors 0
Cincinnati Children's Hospital
Career Start Year 1989
Number of shared co-authors 0
Academic Hospital
Career Start Year 1985
Number of shared co-authors 0
University of Kansas
Career Start Year 1985
Number of shared co-authors 1
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Chugai Pharmaceutical Co. Ltd.
Career Start Year 1984
Number of shared co-authors 0
New York University Winthrop Hospital
Career Start Year 1982
Number of shared co-authors 0
The University of Notre Dame Australia
Career Start Year 1979
Number of shared co-authors 1
Keck School of Medicine, University of Southern California
Career Start Year 1977
Number of shared co-authors 4
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 5
Oita University
Career Start Year 1965
Number of shared co-authors 0
Brigham and Women's Hospital Department of Neurology, and Harvard Medical School
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Co-authored papers 29
The Francis Crick Institute
Co-authored papers 21
National Cancer Institute, National Institutes of Health
Co-authored papers 18
UPMC Hillman Cancer Center
Co-authored papers 11
Co-authored papers 11
University of Colorado School of Medicine
Co-authored papers 6
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Thomas Jefferson University Hospital
Co-authored papers 4
Indiana University School of Medicine
Co-authored papers 4
Ludwig Institute for Cancer Research
Co-authored papers 4
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 3
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Karolinska Institute
Co-authored papers 3
Tulane University School of Medicine
Co-authored papers 3
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Co-authored papers 3
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2